Literature DB >> 29571227

Impact of hyperbaric oxygenation on oxidative stress in diabetic patients.

Sandra Tepić1, Anica Petković2, Ivan Srejović3, Nevena Jeremić2, Vladimir Zivković3, Slobodan Loncarević4, Jovana Bradić2, Vladimir Jakovljević4,5, Miodrag Zivkovć6.   

Abstract

Taking into consideration that a high concentration of oxygen can express toxic effects due to production of reactive oxygen species (ROS), the aim of our investigation was to establish the influence of hyperbaric oxygenation on oxidative stress parameters and antioxidant enzymes in patients with diabetes mellitus (DM) type 2. Investigation included 50 patients with DM type 2 divided into two groups. The first group consisted of 25 patients, mean age 70 years, mean duration of illness 12 years and without manifest peripheral vascular complications (Wagner 0). The second group consisted of 25 patients, mean age 74 years, mean duration of illness 17 years and with manifest peripheral vascular complications (Wagner 1-5). All patients underwent the same therapeutic protocol, which included 10 hyperbaric oxygenation therapies, once a day for a duration of 60 minutes, with an average partial oxygen pressure of 1.7 atmospheres absolute (ATA). In blood samples the following parameters of redox balance were determined: levels of nitrites (NO₂-), index of lipid peroxidation (TBARS), superoxide anion radical (O₂-), hydrogen peroxide (H₂O₂) and antioxidant enzymes superoxide dismutase (SOD) and catalase (CAT). Our results clearly show that hyperbaric oxygen (HBO₂) therapy does not have a pro-oxidative effect. Additionally, it seems that this procedure strongly mobilized the antioxidant enzyme system, thus improving defense from oxidative damage. All significant data are marked as P ⟨0.05. Our results have shown that in terms of ROS production, HBO₂ can be safe to use in patients suffering from DM type 2 with or without vascular complications. Copyright© Undersea and Hyperbaric Medical Society.

Entities:  

Keywords:  diabetes mellitus ; hyperbaric oxygen treatment ; redox status

Mesh:

Substances:

Year:  2018        PMID: 29571227

Source DB:  PubMed          Journal:  Undersea Hyperb Med        ISSN: 1066-2936            Impact factor:   0.698


  3 in total

1.  Ghrelin system is involved in improvements in glucose metabolism mediated by hyperbaric oxygen treatment in a streptozotocin‑induced type 1 diabetes mouse model.

Authors:  Limin Song; Junhua Yuan; Yuan Liu; Di Zhang; Caishun Zhang; Qian Lin; Manwen Li; Kaizhen Su; Yanrun Li; Guangkai Gao; Ruixia Ma; Jing Dong
Journal:  Mol Med Rep       Date:  2020-09-02       Impact factor: 2.952

2.  Association between Vitamin D Supplements, Oxidative Stress Biomarkers, and Hyperbaric Therapy in Patients with Sudden Sensorineural Hearing Loss.

Authors:  Jarosław Paprocki; Paweł Sutkowy; Jacek Piechocki; Alina Woźniak
Journal:  Oxid Med Cell Longev       Date:  2021-03-10       Impact factor: 6.543

3.  Characterization, Hypoglycemic Activity, and Antioxidant Activity of Methanol Extracts From Amomum tsao-ko: in vitro and in vivo Studies.

Authors:  Libin Xie; Dan Yu; Yanan Li; Huidong Ju; Jia Chen; Lianxia Hu; Longquan Yu
Journal:  Front Nutr       Date:  2022-07-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.